Membrane phospholipid alterations in Alzheimer's disease: Deficiency of ethanolamine plasmalogens

Neurochemical Research

Volumn 22, Issue 4, 1997, Pages 523-527

  Farooqui, Akhlaq A ^a   Rapoport, Stanley I ^b   Horrocks, Lloyd A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease; lipid peroxidation; neurodegradation; phospholipase A2; plasma membrane; Plasmalogens; signal transduction

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); ADENOSINE TRIPHOSPHATE; CALCIUM ION; CHOLINE; ETHANOLAMINE; GLYCEROPHOSPHOLIPID; MEMBRANE PHOSPHOLIPID; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE A2; PLASMALOGEN; SERINE; TRITON X 100;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; HUNTINGTON CHOREA; LIPID METABOLISM; LIPID PEROXIDATION; NERVE CELL LESION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030893109     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027380331807     Document Type: Article

References (18)

1. Selkoe, D. J. 1991. The molecular pathology of Alzheimer's disease. Neuron 6:487-498.
2. 2+-channel hypothesis for neuronal death in Alzheimer's Disease. Mol. Cell. Biochem. 140:119-125.
3. Katzman, R., and Saitoh, T. 1991. Advances in Alzheimer's disease. FASEB J. 5:278-286.
4. Farooqui, A. A., Wells, K., and Horrocks, L. A. 1995. Breakdown of membrane phospholipids in Alzheimer's disease: involvement of excitatory amino acid receptors. Molec. Chem. Neuropathol. 25, 155-173.
5. McGeer, P. L., Rogers, J., and McGeer, E. G. 1994. Neuroimmune mechanisms in Alzheimer's disease pathogenesis. Alzheimer Disease and Associated Disorders 8:149-158.
6. Ginsberg, L., Atack, J. R., Rapoport, S. I., and Gershfeld, N. L. 1993. Evidence for a membrane lipid defect in Alzheimer's disease. Mol. Chem. Neuropathol. 19:37-46.
7. Roth, G. S., Joseph, J. A., Mason, R. P. 1995. Membrane alterations in Alzheimer's disease and aging - Reply. Trends. Neurosci. 18:484.
8. Ying, W. 1996. Deleterious network hypothesis of alzheimer's disease. Med. Hypoth. 46:421-428.
9. Farooqui, A. A., Liss, L., and Horrocks, L. A. 1988. Neurochemical aspects of Alzheimer's disease: Involvement of membrane phospholipids. Metabolic Brain Dis. 3:19-35.
10. Nitsch, R., Pittas, A., Blusztajn, J. K., Slack, B. E., Growdon, J. H., and Wurtman, R. J. 1991. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease. Ann. NY Acad. Sci. 640:110-113.
11. Nitsch, R. M., Blusztajn, J. K., Pittas, A. G., Slack, B. E., Growdon, J. H., and Wurtman, R. J. 1992. Evidence for a membrane defect in Alzheimer's disease brain. Proc. Natl. Acad. Sci. USA 89:1671-1675.
12. Söderberg, M., Edlund, C., Kristensson, K., and Dallner, G. 1990. Lipid compositions of different regions of the human brain during aging. J. Neurochem. 54:415-423.
13. Horrocks, L. A., and Fu, S. C. 1978. Pathway for hydrolysis of plasmalogens in brain. Adv. Exp. Med. Biol. 101:397-406.
14. Stokes, C. E., and Hawthorne, J. N. 1987. Reduced phosphoinositide concentration in anterior temporal cortex of Alzheimer's diseased brains. J. Neurochem. 48:1018-1021.
15. Farooqui, A. A., Liss, L., and Horrocks, L. A. 1990. Elevated activities of lipases and lysophospholipases in Alzheimer's disease. Dementia 1:208-214.
16. 31P Nuclear magnetic resonance study of the brain in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 47:235-248.
17. Pettegrew, J. W. 1989. Molecular insights into Alzheimer's disease. Ann. NY Acad. Sci. 568:5-28.
18. Iwamoto, N., Kobayashi, K., and Kosaka, K. 1989. The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients. J. Neurol. 236:80-84.